BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Laryngoscope
,
Valproic acid
,
rs2300478
,
FOXP1
,
cell-cell adhesion
,
HIV infection
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
c JUN
Summary
General Info
Curated Studies
Most Correlated Studies
LNCaP cell line expression with siRNA knockdown of COP1, ETV1, and/or c-JUN
Schwann cells from c-Jun knockout mice with and without sciatic nerve injury
Adenocarcinoma of breast MCF7 cells with c-JUN or RBM39 knockdown & treated with cisplatin
Prostate cancer cells (PC3) with shRNA targeting c-JUN or JUND
AP-1 Transcription Factor c-Jun prevents Stress-Imposed Maladaptive Remodeling of heart
Explore Curated Studies Results
Literature
Most Relevant Literature
Curcumin relieves CFA-induced inflammatory pain by inhibiting the AP-1/c-Jun-CCL2-CCR2 pathway in th…
Chemogenetic neuronal silencing decouples c-Jun activation from cell death in the temporal cortex.
KIF18A Is a Novel Target of JNK1/c-Jun Signaling Pathway Involved in Cervical Tumorigenesis.
c-JUN interacts with HDAC1 as a potential combinatorial therapeutic target in acute myeloid leukemia…
c-JUN is a barrier in hESC to cardiomyocyte transition.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of the Effect of Vinca Alkaloids on c-Jun N-terminal Kinase (JNK) Phosphorylation in Patient…
Efficacy of Injectable Vitamin C on Accelerating Canine Movement: A Clinical Study
Detection of Hepatitis C Infection by Oraquick Test Among Health Care Workers
Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis C
TACE+Tilelizumab+Sorafenib in the Treatment of BCLC Stage C HCC
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ